Dogwood Therapeutics (DWTX) Institutional Ownership $4.88 -0.02 (-0.31%) Closing price 03:58 PM EasternExtended Trading$4.88 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Dogwood Therapeutics (NASDAQ:DWTX)CurrentInstitutional OwnershipPercentage9.05%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$89.85KNumber ofInstitutional Sellers(last 12 months)0 Get DWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Dogwood Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Dogwood Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025FNY Investment Advisers LLC12,500$62K0.0%N/A0.654% 2/12/2025Geode Capital Management LLC10,933$27K0.0%N/A0.822% (Data available from 1/1/2016 forward) DWTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DWTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Dogwood Therapeutics shares: FNY Investment Advisers LLC ($62K), Geode Capital Management LLC ($27K).Learn more on Dogwood Therapeutics' institutional investors. What percentage of Dogwood Therapeutics' stock is owned by institutional investors? 9.05% of Dogwood Therapeutics' stock is owned by institutional investors. Learn more on DWTX's institutional investor holdings. Which institutional investors have been buying Dogwood Therapeutics' stock? The following institutional investors have purchased Dogwood Therapeutics' stock in the last 24 months: FNY Investment Advisers LLC ($12.50K), and Geode Capital Management LLC ($10.93K). How much institutional buying is happening at Dogwood Therapeutics? Institutional investors have bought a total of 23,433 shares in the last 24 months. This purchase volume represents approximately $89.85K in transactions. Related Companies OTLK Major Shareholders CALC Major Shareholders OKUR Major Shareholders RLMD Major Shareholders RANI Major Shareholders MRSN Major Shareholders XLO Major Shareholders MURA Major Shareholders XCUR Major Shareholders RNXT Major Shareholders This page (NASDAQ:DWTX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s new AI play could hand regular Americans a Tesla‑like paydayElon Musk just launched his boldest AI project yet... And if history is any guide — it could make early inv...Behind the Markets | SponsoredCollege grad makes $64,000 a monthNothing hurts like a missed opportunity... And with AI stocks like Nvidia, Palantir, and Oracle continuing...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dogwood Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dogwood Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.